Should natalizumab be used despite JC virus positivity?: No

Should natalizumab be used despite JC virus positivity? No

^*Corresponding author af dette arbejde

@article{fb5e40189286492396e8b836c77c954c,

title = "Should natalizumab be used despite JC virus positivity?: No",

author = "{Dalla Costa}, Gloria and Melinda Magyari and Sorensen, {Per Soelberg}",

year = "2025",

month = jul,

doi = "10.1177/13524585251346382",

language = "English",

volume = "31",

pages = "918--920",

journal = "Multiple Sclerosis Journal",

issn = "1352-4585",

publisher = "SAGE Publications Ltd",

number = "8",

}

TY - JOUR

T1 - Should natalizumab be used despite JC virus positivity?

T2 - No

AU - Dalla Costa, Gloria

AU - Magyari, Melinda

AU - Sorensen, Per Soelberg

PY - 2025/7

Y1 - 2025/7

UR - http://www.scopus.com/inward/record.url?scp=105007157388&partnerID=8YFLogxK

U2 - 10.1177/13524585251346382

DO - 10.1177/13524585251346382

M3 - Journal article

C2 - 40443199

SN - 1352-4585

VL - 31

SP - 918

EP - 920

JO - Multiple Sclerosis Journal

JF - Multiple Sclerosis Journal

IS - 8

M1 - 13524585251346382

ER -